Registered entities
ULTRAGENYX PHARMACEUTICAL,INC
Reg. No. 272546083United States
Ultragenyx Pharmaceutical Inc.
Reg. No. 1515673United States
Social engagement
Social engagement: 115K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include F-Prime Capital, Healthcap, TPG, Pappas Capital; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 58% |
| Private equity | 2 | 17% |
| Other / undisclosed | 3 | 25% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
22 May 2025 · Legal Counsel, North American Brand Attorney · Somerville
6 Dec 2024 · Director, Regulatory Project Management · Somerville
Based on job postings tracked across public sources.
Recent activity
23 Jun 2026
Event
AGSD Conference 2026
17 Jun 2026
Event
18th Annual International Symposium on MPS & Related Lysosomal Diseases
9 Jun 2026
Milestone
regulatory